Chlorpromazine Hcl



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 17.6%
Depression 15.3%
Product Used For Unknown Indication 14.1%
Schizophrenia 11.8%
Bipolar Disorder 8.2%
Overdose 7.1%
Psychotic Disorder 3.5%
Tuberculosis 3.5%
Anxiety 2.4%
Pain 2.4%
Schizophrenia, Disorganised Type 2.4%
Schizophrenia, Paranoid Type 2.4%
Adjustment Disorder 1.2%
Autism 1.2%
Convulsion 1.2%
Drug Withdrawal Syndrome Neonatal 1.2%
Dyspepsia 1.2%
Hiccups 1.2%
Hypertension 1.2%
Insomnia 1.2%
Liver Injury 18.4%
Death 13.2%
Electrocardiogram Qt Prolonged 7.9%
Neuroleptic Malignant Syndrome 7.9%
Lethargy 5.3%
Overdose 5.3%
Serotonin Syndrome 5.3%
White Blood Cell Count Decreased 5.3%
Cellulitis 2.6%
Central Nervous System Inflammation 2.6%
Conjunctivitis 2.6%
Convulsion 2.6%
Drug Rash With Eosinophilia And Systemic Symptoms 2.6%
Hepatocellular Damage 2.6%
Intestinal Infarction 2.6%
Intestinal Obstruction 2.6%
Kidney Malformation 2.6%
Liver Disorder 2.6%
Microcephaly 2.6%
Miosis 2.6%
Secondary
Product Used For Unknown Indication 30.0%
Schizophrenia 16.7%
Insomnia 6.5%
Depression 5.1%
Drug Use For Unknown Indication 4.1%
Parkinsonism 4.0%
Foetal Exposure During Pregnancy 3.8%
Psychotic Disorder 3.6%
Bipolar Disorder 3.3%
Anxiety 3.2%
Major Depression 2.5%
Multiple Sclerosis 2.5%
Self Injurious Behaviour 2.5%
Dissociative Disorder 2.3%
Delusion 1.7%
Maternal Exposure Timing Unspecified 1.7%
Oedema 1.7%
Suicide Attempt 1.7%
Vomiting 1.7%
Binge Drinking 1.5%
Neuroleptic Malignant Syndrome 11.0%
Completed Suicide 8.2%
Multiple Drug Overdose 8.2%
Torsade De Pointes 8.2%
Cholestasis 5.5%
Suicide Attempt 5.5%
Toxicity To Various Agents 5.5%
Ventricular Tachycardia 5.5%
White Blood Cell Count Decreased 5.5%
Aggression 4.1%
Catatonia 4.1%
Death 4.1%
Muscle Rigidity 4.1%
Rhabdomyolysis 4.1%
Abdominal Compartment Syndrome 2.7%
Abdominal Pain 2.7%
Alanine Aminotransferase Increased 2.7%
Cardio-respiratory Arrest 2.7%
Drug Effect Decreased 2.7%
Drug Exposure During Pregnancy 2.7%
Concomitant
Schizophrenia 24.0%
Product Used For Unknown Indication 22.8%
Depression 6.9%
Drug Use For Unknown Indication 5.8%
Prophylaxis 5.7%
Pain 4.3%
Insomnia 3.9%
Multiple Myeloma 3.6%
Anxiety 2.6%
Hypertension 2.3%
Psychotic Disorder 2.3%
Epilepsy 2.1%
Hiv Infection 2.0%
Infection Prophylaxis 1.9%
Bipolar Disorder 1.8%
Bipolar I Disorder 1.7%
Dissociative Disorder 1.7%
Schizophrenia, Paranoid Type 1.7%
Premedication 1.5%
Psychiatric Symptom 1.4%
Water Intoxication 10.1%
Vomiting 7.3%
Weight Decreased 6.4%
White Blood Cell Count Decreased 6.4%
Hyperglycaemia 5.5%
Jaundice 5.5%
White Blood Cell Count Increased 5.5%
Death 4.6%
Loss Of Consciousness 4.6%
Neuroleptic Malignant Syndrome 4.6%
Overdose 4.6%
Pulmonary Embolism 4.6%
Ventricular Tachycardia 4.6%
Hepatic Function Abnormal 3.7%
Muscle Hypertrophy 3.7%
Off Label Use 3.7%
Red Blood Cell Count Decreased 3.7%
Renal Failure 3.7%
Schizophrenia 3.7%
Tremor 3.7%
Interacting
Product Used For Unknown Indication 59.1%
Drug Use For Unknown Indication 13.6%
Schizophrenia 13.6%
Parkinson's Disease 6.8%
Bipolar I Disorder 4.5%
Hypercholesterolaemia 2.3%
Drug Interaction 50.0%
Rhabdomyolysis 25.0%
Urinary Retention 25.0%